Skip to main content
Premium Trial:

Request an Annual Quote

PathGen to Develop Pathogen Detection Test Based on Affymetrix's GeneChip

NEW YORK (GenomeWeb News) – Singapore's PathGen Dx will develop a pathogen detection diagnostic kit based on the Affymetrix GeneChip platform, the companies said today.

PathGen Dx, a spinoff from the Genome Institute of Singapore, plans to develop a test called the PathChip that will detect the presence of more than 70,000 viral and bacterial genomes in human samples and identify co-infecting pathogens.

The company has signed an agreement under the "Powered by Affymetrix" program. Affy will manufacture a GeneChip microarray for PathGen, and the diagnostic kit will include PathGen's proprietary reagents and an automated software package.

The Powered by Affymetrix program also provides PathGen with access to Affy's international distribution network. Other PbA program partners include Roche Diagnostics and Pathwork Diagnostics.

Researchers at GIS began developing the PathChip in 2004. In 2008 the project secured funding from Exploit Technologies, the technology transfer arm of Singapore's Agency for Science, Technology, and Research.

PathGen was recently awarded a Technology Enterprise Commercialization Scheme grant from Singapore's Standards, Productivity and Innovation Board.

The Scan

Wolf Howl Responses Offer Look at Vocal Behavior-Related Selection in Dogs

In dozens of domestic dogs listening to wolf vocalizations, researchers in Communication Biology see responses varying with age, sex, reproductive status, and a breed's evolutionary distance from wolves.

Facial Imaging-Based Genetic Diagnoses Appears to Get Boost With Three-Dimensional Approach

With data for more than 1,900 individuals affected by a range of genetic conditions, researchers compared facial phenotype-based diagnoses informed by 2D or 3D images in the European Journal of Human Genetics.

Survey Suggests Multigene Cancer Panel VUS Reporting May Vary Across Genetic Counselors

Investigators surveyed dozens of genetic counselors working in clinical or laboratory settings, uncovering attitudes around VUS reporting after multigene cancer panel testing in the Journal of Genetic Counseling.

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.